Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)

Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis

NCT01941589 ·Status: COMPLETED ·Phase: PHASE4

Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).

NCT02665845 ·Status: COMPLETED ·Phase: PHASE3

A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC)

NCT04556383 ·Status: TERMINATED ·Phase: PHASE2

Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis

NCT04133194 ·Status: UNKNOWN ·Phase: PHASE4

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

NCT00269438 ·Status: COMPLETED ·Phase: PHASE3

The Colitis Once Daily Asacol Study

NCT00708656 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis

NCT05205603 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease

NCT06878495 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study of Pentasa in Patients With Ulcerative Colitis

NCT01104753 ·Status: COMPLETED

Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis

NCT04857112 ·Status: COMPLETED ·Phase: PHASE2

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase

NCT01257399 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT05644665 ·Status: TERMINATED ·Phase: PHASE3

Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis

NCT00209287 ·Status: TERMINATED ·Phase: PHASE4

Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)

NCT00984568 ·Status: TERMINATED ·Phase: PHASE3

Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis

NCT01257386 ·Status: COMPLETED ·Phase: PHASE3

Fecal Microbiota Transplantation for Ulcerative Colitis

NCT03804931 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT04176588 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis

NCT01458574 ·Status: COMPLETED ·Phase: PHASE3

Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis

NCT00408174 ·Status: COMPLETED ·Phase: PHASE3

Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis

NCT01612039 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis

NCT01059344 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Study of T2 Versus AZA to Maintain Clinical and Endoscopic Remission in Postoperative Crohn's Disease

NCT01015391 ·Status: UNKNOWN ·Phase: NA

Canadian Active & Maintenance Modified Pentasa Study

NCT00603733 ·Status: COMPLETED ·Phase: PHASE3

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

NCT03945188 ·Status: COMPLETED ·Phase: PHASE3

Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis

NCT01320436 ·Status: COMPLETED ·Phase: PHASE3